According to Pharmaxis latest financial reports the cash on hand of PXS is $6.24M, an increase of 3.28% to 2022. At the end of 2022 company had $6.05M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $6.24M | 3.28% |
2022 | $6.05M | -52.24% |
2021 | $12.66M | 26.74% |
2020 | $9.99M | -52.56% |
2019 | $21.06M | - |